Does rosehip oil fade scars? What the surgical-scar trials found

People often reach for rosehip oil because of claims it softens or improves the appearance of surgical scars. The clinical literature on that question is small: a recent review identified only two human clinical trials that examined rosehip for postsurgical scars and concluded the evidence is scarce and inconclusive.¹

Outside those two trials the published work is mostly lab and animal research, and studies of dressings or delivery systems that include rosehip as one ingredient. Those kinds of studies can suggest mechanisms but do not settle whether topical rosehip oil meaningfully changes scar appearance on people over time.^2,3,4,5

What the trials and the lab work actually measured

The human evidence is reported only in narrative reviews; the reviews say two clinical trials exist and that topical rosehip formulations may reduce scar size and erythema, but they do not present a pooled, high-quality estimate of effect and emphasize the small number and limited quality of the trials.¹

The mechanistic and preclinical studies focus on early wound-healing endpoints rather than mature scar remodeling. In cell cultures and in vitro scratch assays, rosehip-containing materials and rosehip oil increased fibroblast migration and accelerated wound closure compared with controls.^2,3

In rodent excisional-wound models, topical rosehip seed oil raised markers associated with repair — higher VEGF and TGF‑β expression, faster closure of the excision, and histologic signs of epithelial regeneration — and in one study rosehip oil accelerated the macrophage shift from an inflammatory to a reparative phenotype, a change the authors linked to improved scar metrics and altered collagen I/III ratios. These are animal models of acute wounds rather than randomized human scar trials.^3,4

Other work tests rosehip in delivery systems: rosehip used to make antioxidant, cell‑friendly nanofibres for wound dressings showed improved fibroblast migration and antioxidant activity in vitro, and nanoemulsion formulations containing rosehip oil altered skin penetration and impacted healing in an ex vivo human skin wound model. Those studies show rosehip can be active in engineered formulations, but they are not trials of plain rosehip oil on post‑surgical scars in living people.^2,5

Fresh surgical wounds versus old acne or mature scars

Most positive signals come from fresh wounds and early healing stages: rodent excisions and in vitro scratch assays model the inflammatory and proliferative phases of wound repair, where antioxidants, fatty acids and modulators of macrophage phenotype can plausibly change the course of healing.^2,3,4

That pattern matters because mature surgical scars and old acne scars are biologically different. Remodeling of long‑standing scar tissue involves established collagen architecture and reduced cellularity; interventions that speed early closure or damp inflammation may have meaningful effects on new scars but do not necessarily translate to improvement of years‑old scarring. The provided literature does not include trials testing rosehip on mature acne scars.^1,4

How rosehip stacks up against standard scar care

None of the abstracts in this set reports a head‑to‑head comparison between rosehip oil (or rosehip‑only formulations) and commonly recommended medical interventions for scars. The recent review that surveyed the human trials noted the scarcity of high‑quality studies and did not present direct comparisons to standard therapies. From the material available here, we cannot say whether rosehip is better, worse, or equivalent to established treatments.^1,6

Some studies do test rosehip within dressings or as part of a nanoemulsion, and those experiments show delivery method affects penetration and cellular response. Those results underline a practical point: a formulation that contains rosehip plus other ingredients or that changes skin penetration is not evidence that plain rosehip oil on its own will produce the same outcome.^2,5

Our grade and what a better study would look like

Grade: C−. The available work offers biologically plausible mechanisms and consistent signals in cells and animals that rosehip components can influence wound‑healing pathways and early scar formation, but human data are very limited, and no robust, blinded, well‑powered randomized comparisons appear in this set of abstracts. The recent reviews emphasize that the human clinical base is small and insufficient to make firm recommendations.^1,3,4

A definitive clinical trial would be randomized, double‑blind, and compare a plain rosehip oil formulation to an active standard (an established topical scar therapy) and to a placebo or no‑treatment control. Outcomes should include validated scar scales, objective colorimetry and thickness measures, and at least six to twelve months of follow‑up to capture remodeling. Trials should report sample size calculations and be preregistered. Parallel mechanistic sampling (biopsies or biomarkers) would help link clinical effects to the macrophage, collagen or antioxidant pathways implicated in the preclinical work.

Practical takeaways

If you are considering rosehip oil for a fresh surgical scar, the evidence base includes a couple of small human trials and several supportive lab and animal studies showing faster wound closure, greater fibroblast migration, antioxidant activity, and shifts in macrophage phenotype that could plausibly improve early scar appearance. But the human trial data are sparse and not definitive.^1,2,3,4

For long‑standing acne scars there is no direct clinical evidence in the material provided here to support benefit. And because many studies test rosehip inside dressings or delivery systems, a study of a branded formulation should not be taken as proof that plain rosehip oil will produce the same result. See a dermatologist for persistent or cosmetically significant scarring.^1,5